CALC Reports $0 Revenue, Advances Auxora in Acute Pancreatitis Pivotal Program, CM5480 Preclinical Data Published in JCI Insight for PAH Treatment
CalciMedica, Inc. Common Stock · Now $0.84
+45% since the alert
$0.58 → $0.84
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS